M. Chirara

721 total citations
7 papers, 85 citations indexed

About

M. Chirara is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, M. Chirara has authored 7 papers receiving a total of 85 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in M. Chirara's work include Hepatitis C virus research (4 papers), Hepatitis B Virus Studies (3 papers) and HIV Research and Treatment (3 papers). M. Chirara is often cited by papers focused on Hepatitis C virus research (4 papers), Hepatitis B Virus Studies (3 papers) and HIV Research and Treatment (3 papers). M. Chirara collaborates with scholars based in Zimbabwe, United Kingdom and Uganda. M. Chirara's co-authors include Christopher J. Chetsanga, Pontiano Kaleebu, Cissy Kityo, Michael C. Kew, Yasuhito Tanaka, Deenan Pillay, Anna Kramvis, Ruth Goodall, Adele McCormick and Ravindra K. Gupta and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, AIDS and Journal of Medical Virology.

In The Last Decade

M. Chirara

7 papers receiving 84 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Chirara Zimbabwe	6	60	50	35	22	5	7	85
Akaki Abutidze Georgia	7	147 2.5×	112 2.2×	53 1.5×	26 1.2×	6 1.2×	28	176
J. Koffi France	4	73 1.2×	74 1.5×	56 1.6×	19 0.9×	3 0.6×	6	98
Tânia Reuter Brazil	7	58 1.0×	35 0.7×	41 1.2×	10 0.5×	2 0.4×	19	94
Stephanie Popping Netherlands	6	76 1.3×	39 0.8×	64 1.8×	9 0.4×	4 0.8×	12	111
Leon Claude Sidi Brazil	4	34 0.6×	25 0.5×	36 1.0×	16 0.7×	7 1.4×	4	58
Raffaele Dell’Acqua Italy	6	35 0.6×	33 0.7×	46 1.3×	26 1.2×		9	81
Hannah Hussey South Africa	6	53 0.9×	33 0.7×	23 0.7×	14 0.6×	1 0.2×	9	93
Arlette Emième Ivory Coast	6	63 1.1×	40 0.8×	57 1.6×	29 1.3×	1 0.2×	9	93
Alexandra Tejada‐Strop United States	9	99 1.6×	139 2.8×	49 1.4×	7 0.3×	4 0.8×	14	158
Bao-Chau Phung France	5	62 1.0×	42 0.8×	22 0.6×	20 0.9×	1 0.2×	6	76

Countries citing papers authored by M. Chirara

Since Specialization

Citations

This map shows the geographic impact of M. Chirara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Chirara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Chirara more than expected).

Fields of papers citing papers by M. Chirara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Chirara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Chirara. The network helps show where M. Chirara may publish in the future.

Co-authorship network of co-authors of M. Chirara

This figure shows the co-authorship network connecting the top 25 collaborators of M. Chirara. A scholar is included among the top collaborators of M. Chirara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Chirara. M. Chirara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Dunn, David, M. Chirara, Cissy Kityo, et al.. (2017). Hepatitis B serological markers and plasma DNA concentrations. AIDS. 31(8). 1109–1117. 13 indexed citations

2.

Dolling, David, Ruth Goodall, M. Chirara, et al.. (2017). The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data. BMC Infectious Diseases. 17(1). 160–160. 3 indexed citations

3.

McCormick, Adele, Chris M. Parry, Ruth Goodall, et al.. (2011). Impact of the N348I Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1. Antimicrobial Agents and Chemotherapy. 55(4). 1806–1809. 17 indexed citations

4.

Chirara, M., et al.. (2010). Molecular characterization of hepatitis B virus isolates from Zimbabwean blood donors. Journal of Medical Virology. 83(2). 235–244. 14 indexed citations

5.

Pillay, Deenan, Ruth Goodall, Charles F. Gilks, et al.. (2010). Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa. Journal of the International AIDS Society. 13. O20–O20. 7 indexed citations

6.

Chirara, M., Grazyna Stanczuk, S. A. Tswana, et al.. (2001). Low risk and high risk human papillomaviruses (HPVs) and cervical cancer in Zimbabwe: epidemiological evidence. Central African Journal of Medicine. 47(2). 32–5. 5 indexed citations

7.

Chirara, M. & Christopher J. Chetsanga. (1994). Variant of hepatitis B virus isolated in zimbabwe. Journal of Medical Virology. 42(1). 73–78. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact